About the Company
We do not have any company description for iBio, Inc. at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $IBIO News
Micro-Cap Stock iBio Doubles On Wednesday - Here's Why
iBio Inc (NYSE:IBIO) shares are surging after the company entered into a collaboration agreement with AstralBio Inc. on Wednesday to discover, engineer, and develop antibodies to treat obesity and ...
iBio Announces $15.0 Million Private Placement
Purchase price of $2.85 represents a premium of 148+% to last close – BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an ...
iBio Inc IBIO
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Why Has iBio Inc (AMEX: IBIO) Declined So Much?
iBio Inc (AMEX:IBIO) traded at $2.11 at close of the session on Friday, April 05, made a downward move of -15.26% on its previous day’s price.
IBio In Partnership With AstralBio; Shares Up In Pre-market
(RTTNews) - iBio, Inc. (IBIO) Wednesday announced partnership with AstralBio, Inc. to develop novel antibodies to treat obesity and other cardiometabolic conditions. iBio shares were up more than ...
iBio Announces Reverse Stock Split
iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”) today announced that its Board of Directors has approved a 20-to-1 reverse split of the Company’s common stock, par value $0.001 per ...
iBio Announces $15.0 Million Private Placement
BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announces ...
iBio Inc
What Is a Stock Market Correction? Investors may be shaken by a drop of 10% or more in a stock market index, but corrections are par for the course.
Loading the latest forecasts...